SILIFAT JONES-IBRAHIM: Open Payments
NPI 1235850876 · HOMEWOOD, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$985 in 45 payments from 12 companies in 2025. Trend: 2023 $344 · 2024 $861 · 2025 $985
Food & beverage: $885Education: $100
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $240 |
| Otsuka America Pharmaceutical, Inc. | 16 | $225 |
| Alkermes, Inc. | 3 | $104 |
| ABBVIE INC. | 4 | $86 |
| Lundbeck LLC | 3 | $75 |
| Neurocrine BioSciences, Inc. | 3 | $72 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $45 |
| Janssen Pharmaceuticals, Inc | 1 | $25 |
| Supernus Pharmaceuticals, Inc. | 1 | $23 |
Products named: ABILIFY ASIMTUFII, VRAYLAR, AUSTEDO XR, LYBALVI, INGREZZA, UZEDY, Auvelity, CAPLYTA.
Industry payments across IL — which companies pay providers there.
